Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection

Article Abstract:

HIV patients with progressive multifocal leukoencephalopathy do not appear to benefit from the drug cytabarine or the typical drugs used to treat AIDS. Progressive multifocal leukoencephalopathy is a viral infection of the brain that is enhanced by prolonged immunosuppression. Researchers randomly assigned 57 HIV patients with this infection to take the AIDS drug zidovudine plus didanosine or stavudine or cytarabine administered in two different ways. Only 7 patients completed the 24-week treatment, and survival rates were similar in all three groups.

Evaluation, HIV infection, Drug therapy, HIV infections, Cytarabine

---

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

Article Abstract:

Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab as a result of which an evaluation was conducted to determine whether PML had developed in any other treated patients. In conclusion, no cases of PML were found in patients treated with natalizumab

England, Risk factors, Natalizumab

---

Similar abstracts:

• Abstracts: Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.